Aparnaa Ananthakrishnan

I utilize the computational algorithm DeepCDR to conduct Drug Target Interaction screening and predict IC50 values (toxicity indicators to determine which novel cancer drugs, potentially, have the ability to inhibit the progression of colon cancer.
Presented research findings at the Fall (2021) and Summer(2022) ASDRP Symposium. Presented at the American Chemical Society’s Western Conference in Las Vegas on October 21st, 2022.